Table 1:
Demographic Characteristics at Time of DXA for All Patients by Study Group
| Characteristic | Physician-Managed (n = 549 DXA scansa) |
Pharmacist-Managed (n = 466 DXA scansa) |
p-value |
|---|---|---|---|
| Age (yrs), mean ± SD | 73.36 ± 6.5 | 75.26 ± 7.2 | < 0.001 |
| Race, n (%) | 0.084 | ||
| Caucasian | 471 (86.1) | 421 (90.3) | |
| African American | 52 (9.5) | 25 (5.4) | |
| Hispanic | 4 (0.7) | 5 (1.1) | |
| Height (cm), mean ± SD | 160.7 ± 8.1 | 160.0 ± 7.0 | 0.208 |
| Weight (kg), mean ± SD | 72.6 ± 16.8 | 68.3 ± 14.6 | < 0.001 |
| BMD (g/cm2), mean ± SD | |||
| Lumbar spine | 1.14 ± 0.208 | 1.07 ± 0.201 | < 0.001 |
| Right femoral neck | 0.836 ± 0.127 | 0.780 ± 0.124 | < 0.001 |
| Left femoral neck | 0.837 ± 0.134 | 0.797 ± 0.501 | 0.078 |
| Radius | 0.740 ± 0.125 | 0.695 ± 0.121 | < 0.001 |
| T-scores, mean ± SD | |||
| Lumbar spine | −0.340 ± 1.705 | −0.861 ± 1.642 | < 0.001 |
| Right femoral neck | −1.418 ± 0.938 | −1.840 ± 0.899 | < 0.001 |
| Left femoral neck | −1.411 ± 0.967 | −1.855 ± 0.989 | < 0.001 |
| Radius | −1.531 ± 1.494 | −2.055 ± 1.384 | < 0.001 |
| FRAX Scores, mean ± SD | |||
| Major osteoporotic | 12.99 ± 4.83 | 14.71 ± 6.53 | < 0.001 |
| Hip fracture | 2.95 ± 2.19 | 4.39 ± 4.24 | < 0.001 |
| Fracture historyb, n (%) | 156 (28.4) | 155 (33.2) | 0.101 |
| High risk, n (%) | 237 (43.2) | 311 (66.7) | < 0.001 |
| High risk based on T-score | 122 (22.2) | 224 (48.1) | < 0.001 |
| High risk based on FRAX | 135 (42.6) | 174 (56.3) | 0.001 |
| High risk based on both T-score and FRAX | 20 (3.6) | 87 (18.7) | < 0.001 |
| TSH (uIU/mL), mean ± SD | 3.37 ± 20.02 | 2.31 ± 2.25 | 0.463 |
| Vitamin Dc (pg/ml), mean ± SD | 35.1 ± 14.2 | 36.3 ± 14.0 | 0.574 |
| Documented ADR to antifracture therapyd, n (%) | 24 (4.4) | 38 (8.2) | 0.012 |
| Alcohol usee, n (%) | 18 (3.3) | 16 (3.4) | 0.891 |
| Current smoker, n (%) | 23 (4.2) | 31 (6.7) | 0.081 |
a
Unique patients: n = 347 physician-managed group, n = 277 unique patients pharmacist-physician collaboration, n = 62 patients with DXAs in both groups
b
Determined by the patient’s response on the pre-procedure DXA scan form.
c
Total 25-hydroxy vitamin D
d
Determined from review of chart notes within one year of DXA and documented allergies.
e
Defined as a documented alcohol consumption of > 3 drinks per day within the patient’s social history or chart note or patient response on the pre-procedure DXA scan form.